Drug appraisal issues must be resolved at policy level

BMJ. 2016 Aug 23:354:i4519. doi: 10.1136/bmj.i4519.

Authors

Katharina Kieslich¹, Peter Littlejohns¹, Albert Weale²

Affiliations

¹ King's College, London, Division of Health and Social Care Research, Addison House, Guy's Campus, London SE1 1U, UK.
² School of Public Policy, University College London, London WC1H 9QU, UK.

PMID: 27554832
DOI: 10.1136/bmj.i4519

No abstract available

Publication types

Letter

MeSH terms

Drug Costs*
England
Health Policy*
Hepatitis C / drug therapy*
Humans